Skip to main content
Premium Trial:

Request an Annual Quote

Virogenomics to Use $2M NIST Grant to Develop Portable Multiplex Assay

NEW YORK (GenomeWeb News) - Virogenomics said today that it has won a $2 million grant from the National Institute of Standards and Technology to develop a handheld assay that would test for multiple biomarkers at once.
 
The grant was awarded under NIST's Advanced Technology Program. The company said it is developing the technology, which it calls the Sensor System on Panel, or SSOP, test with a number of collaborators, including Sharp Labs of America's Materials and Device Applications Lab, Portland State University, Oregon Health & Science University School of Medicine, and the Portland Veterans Administration Medical Center.
 
The SSOP test will screen for autoimmune diseases, allergies, cancers, and infectious diseases, and is based on technology the company licensed from Oregon Health & Science University.
 
The company said that the SSOP “will include all the hardware and firmware required to do a complete analysis of the interaction of biological molecules and communicate the result.”
 
The device is expected to be “the size and shape of a typical USB flash drive, and could be read on a standard personal computer through a USB port,” the company said.
 
"The ability to rapidly screen for multiple disease markers and antibodies in real time on a microchip will enable healthcare providers to make on-the-spot medical decisions," said OHSU researcher Arthur Vandenbark, a co-inventor of one of the biochip designs to be developed for the SSOP.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.